We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1.
- Authors
Heatwole, Chad R; Eichinger, Katy J; Friedman, Deborah I; Hilbert, James E; Jackson, Carlayne E; Logigian, Eric L; Martens, William B; McDermott, Michael P; Pandya, Shree K; Quinn, Christine; Smirnow, Alexis M; Thornton, Charles A; Moxley, Richard T, 3rd
- Abstract
To evaluate the safety and tolerability of recombinant human insulin-like growth factor 1 (rhIGF-1) complexed with IGF binding protein 3 (rhIGF-1/rhIGFBP-3) in patients with myotonic dystrophy type 1 (DM1).
- Publication
Archives of neurology, 2011, Vol 68, Issue 1, p37
- ISSN
1538-3687
- Publication type
Journal Article
- DOI
10.1001/archneurol.2010.227